STOCK TITAN

Planned 988-share sale in issuer (NASDAQ: VRTX) disclosed

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder filed a notice of proposed sale of 988 shares of common stock, to be sold through Fidelity Brokerage Services LLC on or about 02/13/2026 on NASDAQ. The filing notes that 253,718,831 shares of the class were outstanding.

The shares to be sold were acquired via restricted stock vesting from the issuer as compensation, with 347 shares vesting on 10/01/2025 and 641 shares vesting on 02/10/2026. The shareholder, Jonathan Biller, previously sold 347 shares on 12/03/2025 for gross proceeds of 155,803.00 and 1,925 shares on 02/11/2026 for gross proceeds of 886,327.75.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for VRTX report about upcoming share sales?

The notice reports a planned sale of 988 common shares through Fidelity Brokerage Services LLC on or about 02/13/2026 on NASDAQ. It also states that the class has 253,718,831 shares outstanding.

How were the VRTX shares in this Form 144 acquired by the seller?

The shares were acquired through restricted stock vesting from the issuer as compensation. 347 shares vested on 10/01/2025 and 641 shares vested on 02/10/2026, both identified as compensation-based awards.

Who is the selling security holder in the VRTX Form 144 filing?

The selling security holder identified is Jonathan Biller, with an address at 50 Northern Avenue, Boston, MA 02210. He is listed as the person for whose account the securities are to be sold and appears as the seller in recent transactions.

What recent VRTX share sales has the Form 144 seller completed?

The seller completed two sales of common shares in the past three months: 347 shares on 12/03/2025 for 155,803.00 in gross proceeds and 1,925 shares on 02/11/2026 for 886,327.75 in gross proceeds.

On which exchange will the VRTX shares in this Form 144 be sold?

The filing specifies that the 988 common shares covered by the notice are intended to be sold on NASDAQ. The broker named for the transaction is Fidelity Brokerage Services LLC, located in Smithfield, Rhode Island.

What is the total number of VRTX shares outstanding referenced in the Form 144?

The notice states that there are 253,718,831 shares of the relevant class of common stock outstanding. This figure provides context for the proposed sale of 988 shares disclosed in the filing.

Vertex Pharmaceuticals Inc

NASDAQ:VRTX

VRTX Rankings

VRTX Latest News

VRTX Latest SEC Filings

VRTX Stock Data

117.98B
253.12M
0.14%
98.18%
1.42%
Biotechnology
Pharmaceutical Preparations
Link
United States
BOSTON